World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
97
Citations
37128
World Ranking
815
National Ranking
73

Medicine

D-Index
97
Citations
37129
World Ranking
9228
National Ranking
898

Overview

Jane A. McKeating is affiliated with the University of Oxford in the United Kingdom. Their research primarily focuses on the field of Medicine, with significant contributions across various subfields including Epidemiology, Infectious Diseases, Molecular Biology, Hepatology, and Immunology.

The scientist's work covers several key topics, notably:

  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • SARS-CoV-2 and COVID-19 Research
  • Liver Disease Diagnosis and Treatment
  • Circadian rhythm and melatonin
  • Tryptophan and brain disorders
  • COVID-19 Clinical Research Studies

Jane A. McKeating has published in a variety of journals, with frequent appearances in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Journal of General Virology
  • Reviews in Medical Virology
  • iScience

Notable recent papers include:

  • "Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment" (2021) - iScience
  • "An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease" (2021) - Nature Immunology
  • "Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells" (2021) - Cell Reports
  • "Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint" (2021) - Nature Communications
  • "Accurate targeted long-read DNA methylation and hydroxymethylation sequencing with TAPS" (2020) - Genome Biology

The scientist collaborates frequently with several researchers, including:

  • Peter A. C. Wing
  • Xiaodong Zhuang
  • James Michael Harris
  • Peter Balfe
  • Andrea Magrì

Best Publications

  • Complete Replication of Hepatitis C Virus in Cell Culture

    Brett D. Lindenbach;Brett D. Lindenbach;Brett D. Lindenbach;Matthew J. Evans;Matthew J. Evans;Matthew J. Evans;Andrew J. Syder;Andrew J. Syder;Andrew J. Syder;Benno Wölk;Benno Wölk;Benno Wölk

  • Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.

    Matthew J. Evans;Thomas von Hahn;Donna M. Tscherne;Andrew J. Syder

  • Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication

    Keril J. Blight;Jane A. McKeating;Charles M. Rice

  • Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor Usage

    Janis V. Giorgi;Lance E. Hultin;Jane A. McKeating;Timothy D. Johnson

  • Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.

    Mayla Hsu;Jie Zhang;Mike Flint;Carine Logvinoff

  • EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

    Joachim Lupberger;Mirjam B Zeisel;Mirjam B Zeisel;Fei Xiao;Fei Xiao;Christine Thumann;Christine Thumann

  • Dissociation of gp120 from HIV-1 virions induced by soluble CD4.

    John P. Moore;Jane A. McKeating;Robin A. Weiss;Quentin J. Sattentau

  • Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

    Mansun Law;Toshiaki Maruyama;Jamie Lewis;Erick Giang

  • Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81

    Mike Flint;Catherine Maidens;Larry D. Loomis-Price;Christine Shotton

  • Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

    Brett D. Lindenbach;Philip Meuleman;Alexander Ploss;Thomas Vanwolleghem

  • Neutralizing antibody response during acute and chronic hepatitis C virus infection

    Carine Logvinoff;M E Major;D Oldach;S Heyward

  • Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR

    Stefan Pöhlmann;Jie Zhang;Frédéric Baribaud;Zhiwei Chen

  • Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry

    Donna M. Tscherne;Christopher T. Jones;Matthew J. Evans;Brett D. Lindenbach

  • MAIT cells are activated during human viral infections

    B van Wilgenburg;I Scherwitzl;E C Hutchinson;T Leng

  • Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo

    Thomas von Hahn;Joo Chun Yoon;Harvey Alter;Charles M. Rice

  • CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.

    Jie Zhang;Glenn Randall;Adrian Higginbottom;Peter Monk

  • Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies.

    Jennifer M. Timpe;Zania Stamataki;Adam Jennings;Ke Hu

  • Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture

    Keril J. Blight;Jane A. McKeating;Joseph Marcotrigiano;Charles M. Rice

  • Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.

    J. P. Moore;J. A. Mckeating;Yaoxing Huang;A. Ashkenazi

  • Viral hepatitis and liver cancer.

    Marc Ringehan;Marc Ringehan;Jane A. McKeating;Jane A. McKeating;Ulrike Protzer;Ulrike Protzer

Frequent Co-Authors

Peter Balfe
Peter Balfe University of Oxford
Thomas F. Baumert
Thomas F. Baumert University of Strasbourg
Mirjam B. Zeisel
Mirjam B. Zeisel University of Strasbourg
Charles M. Rice
Charles M. Rice Rockefeller University
David H. Adams
David H. Adams Mount Sinai Hospital
Ulrike Protzer
Ulrike Protzer Technical University of Munich
Paul D. Griffiths
Paul D. Griffiths University College London
John P. Moore
John P. Moore Cornell University
Arvind H. Patel
Arvind H. Patel University of Glasgow
Stefan G. Hubscher
Stefan G. Hubscher University of Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to diverse healthcare careers, often requiring advanced nursing roles like Nurse Practitioners (NPs) who specialize in mental health or acute care. For those interested in psychiatric nursing, exploring the best online psychiatric mental health nurse practitioner programs can offer valuable clinical placement opportunities and foundational training.

Cost is a major consideration when choosing a program. Fortunately, there are several cheap psych NP programs available that provide quality education without excessive financial burden, making advanced practice nursing more accessible.

Career advancement also involves understanding potential earnings. Reviewing the DNP salary by state data helps candidates set realistic expectations and negotiate effectively based on geographic location and market demand for Doctor of Nursing Practice graduates.

For nurses seeking to broaden their scope, transitioning from FNP to ACNP is a strategic move that allows a focus on acute care settings. This pathway supports Immunology-related healthcare roles requiring critical care expertise and specialized clinical skills.

Best Scientists Citing Jane A. McKeating

Trending Scientists

Recently Published Articles